Nanoparticle-Proton combo for recurrent cancer study pulled before start
NCT ID NCT04784221
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study aimed to test a new treatment for people whose cancer returned after previous radiation therapy. The approach combined special nanoparticles injected into the blood with targeted proton therapy to try to control the tumor. The study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.